Tag: biopharmaceutical company
This ‘Strong Buy’ Stock Is Trading at New 20-Year Highs
Insmed (INSM) is a biopharmaceutical company with strong momentum. Shares are trading at...
Why Bristol-Myers Squibb (BMY) Deserves a Spot in Passive Income Portfolios
Bristol-Myers Squibb Company (NYSE:BMY) is included among the 12 Best Stocks to Buy Now for Passive...
These 2 Stocks Could Be Prime Takeover Targets, According to Analysts
What began as a cautious ride earlier in the year has swelled into a full-blown bull...
Is it a Wise Move to Buy Liquidia Corp. (LQDA) Shares?
Arquitos Capital Management, an investment management firm, released its second-quarter 2025 investor letter. During the period,...
Structure Therapeutics Inc. (GPCR) Eyes Major 2025 Catalyst With Phase 2b Obesity Data
In this article, we will be taking a look at the Top 10 AI-Powered Biotech Stocks...
Here’s How You Can Earn $100 In Passive Income By Investing In Gilead Sciences Stock
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the...
Jim Cramer Recommends Eli Lilly Over Viking Therapeutics
Viking Therapeutics, Inc. (NASDAQ:VKTX) is one of the stocks Jim Cramer shared insights on. When...
Ardelyx, Inc. (ARDX) Strengthens Global Reach with Kyowa Kirin Deal
We recently published 10 Best Biotech Stocks to Buy Under $10. Ardelyx, Inc....
Pfizer Stock: Analyst Estimates & Ratings
With a market cap of $138.2 billion, Pfizer Inc. (PFE) is a leading global biopharmaceutical company headquartered...